This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
A healthy relationship between sites and sponsors is critical to the success of clinicaltrials, including efficient and effective management, adaptability, innovation, problem-solving, and feedback mechanisms on the parts of those involved on both sides.
Introduction: Clinicaltrials are essential for evaluating the safety and efficacy of new medical treatments, therapies, and interventions. Developing an accurate and comprehensive budget is crucial for successful trial planning and execution. Site Selection: Careful site selection is critical for optimizing trial costs.
“We often hear that clinicalresearch professionals ‘accidentally happened upon’ this career path,” adds Lisa Lionetti-Freutel, CCRC, ClinicalResearchCoordinator at Renown Health.
Among many other topics, speakers at this weekend’s ACRP 2023 gathering in Dallas, Texas, are sharing insights on the importance of building quality into clinicaltrials and increasing diversity among the staff and patients at the study site level. At the trial level, the protocol is the blueprint for quality.
It wasn’t just the resignation of yet another clinicalresearchcoordinator (CRC) that Christina Brennan, MD, CCRC, vice president for clinicalresearch at Northwell Health, had to contend with earlier this year. Welcome to the war for clinicaltrial talent, 2022 style. We have approximately 2.5
That’s part of the reason why Sara Abbassi, MBBS, MSPH, a clinicalresearchcoordinator (CRC) at Wellnext LLC and ACRP member, says that educating patient advocacy groups about clinicalresearch is a critical component of the profession.
In recognition of October being Breast Cancer Awareness Month , ACRP recently went behind the scenes with a clinicalresearchcoordinator on the study team for a bold Cleveland Clinic investigation of a vaccine aimed at preventing triple-negative breast cancer (TNBC), the most aggressive and lethal form of the disease.
In areas with large Latino populations, it’s essential to have clinicalresearchcoordinators, data managers, and principal investigators—among other professionals—who understand the cultural nuances and can build relationships. One major development is the expansion of clinicaltrials into Latin America.
That’s part of the reason why Sara Abbassi, MBBS, MSPH, a clinicalresearchcoordinator (CRC) at Wellnext LLC and ACRP member, says that educating patient advocacy groups about clinicalresearch is a critical component of the profession.
There is a growing expectation that clinicaltrial sites should be tech-enabled, based on experiences during the COVID-19 pandemic and even earlier. There are often multiple platforms, which can differ by sponsor, leaving our clinicalresearchcoordinators (CRCs) drowning in passwords for access to the various portals.”.
In recognition of October being Breast Cancer Awareness Month , ACRP recently went behind the scenes with a clinicalresearchcoordinator on the study team for a bold Cleveland Clinic investigation of a vaccine aimed at preventing triple-negative breast cancer (TNBC), the most aggressive and lethal form of the disease.
I started as a clinicalresearchcoordinator (CRC) working directly with patients. I I moved into the clinicalresearch associate (CRA) role and then was a clinicaltrial manager (CTM) where I was managing and partnering with sites. Ince: I have been in the industry for 20 years. I
We organize all of the trending information in your field so you don't have to. Join 21,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content